Detalhe da pesquisa
1.
Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study.
Blood
; 142(26): 2327-2331, 2023 12 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37738563
2.
Prognostic relevance of circulating lymphoma cells at diagnosis in newly diagnosed follicular lymphoma patients.
Hematol Oncol
; 42(3): e3278, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38726682
3.
The impact of increasing karyotypic complexity and evolution on survival in patients with CLL treated with ibrutinib.
Blood
; 138(23): 2372-2382, 2021 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34314481
4.
Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers.
Blood
; 137(3): 374-386, 2021 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32663292
5.
Effect of cumulative dose of brentuximab vedotin maintenance in relapsed/refractory classical Hodgkin lymphoma after autologous stem cell transplant: an analysis of real-world outcomes.
Haematologica
; 108(11): 3025-3032, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37102592
6.
Patient characteristics that predict Richter's transformation in patients with chronic lymphocytic leukemia treated with ibrutinib.
Am J Hematol
; 98(1): 56-65, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36216791
7.
Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centers.
Am J Hematol
; 98(6): 900-912, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36965007
8.
Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study.
Haematologica
; 106(7): 1932-1942, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33538152
9.
Intensive induction regimens after deferring initial therapy for mantle cell lymphoma are not associated with improved survival.
Eur J Haematol
; 107(3): 301-310, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33973276
10.
Multi-center analysis of practice patterns and outcomes of younger and older patients with mantle cell lymphoma in the rituximab era.
Am J Hematol
; 96(11): 1374-1384, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34324220
11.
Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure.
Cancer
; 126(2): 293-303, 2020 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31568564
12.
Poor outcomes for double-hit lymphoma patients treated with curative-intent second-line immunochemotherapy following failure of intensive front-line immunochemotherapy.
Br J Haematol
; 189(2): 313-317, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31804715
13.
Bruton tyrosine kinase inhibitors for the treatment of mantle cell lymphoma: review of current evidence and future directions.
Clin Adv Hematol Oncol
; 17(4): 223-233, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31188814
14.
TRES, a validated three-factor comorbidity score, is associated with survival in older patients with mantle cell lymphoma.
Haematologica
; 108(11): 3110-3114, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37226703
15.
Post-infusion PD-1+CD8+CAR-T cells identify patients responsive to CD19-CAR-T therapy in non-Hodgkin's lymphoma.
Blood Adv
; 2024 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38607381
16.
Time to progression of disease and outcomes with second-line BTK inhibitors in relapsed/refractory mantle cell lymphoma.
Blood Adv
; 7(16): 4576-4585, 2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37307169
17.
A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma.
Cancers (Basel)
; 15(5)2023 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36900230
18.
Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma.
Blood Adv
; 7(11): 2287-2296, 2023 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36516079
19.
EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort.
Leuk Lymphoma
; 64(5): 1026-1034, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36960939
20.
High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study.
Blood Adv
; 7(21): 6381-6394, 2023 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37171397